Inhibition of lymphoproliferation by hyperlipoproteinemic plasma
- PMID: 184112
- PMCID: PMC333258
- DOI: 10.1172/JCI108548
Inhibition of lymphoproliferation by hyperlipoproteinemic plasma
Abstract
Plasma for patients with primary type IV or V hyperlipoproteinemia inhibited [3H]thymidine incorporation by cultured mononuclear leukocytes. This previously unreported abnormality affected mononuclear leukocytes from patients with type IV or V hyperlipoproteinemia and from normal subjects. Patient cells incorporated [3H]thymidine normally when washed and incubated in medium containing normal plasma. Both spontaneous incorporation and stimulated incorporation in response to various mitogens and antigens were inhibited. The inhibitory effect was identified with the chylomicron and very low density lipoprotein fractions isolated from plasma and was concentration-dependent. Lectin used to stimulate cultured cells and [3H]thymidine used to measure responses were not bound to the lipoproteins in appreciable amounts. [3H]-Thymidine incorporation correlated well with morphologic evidence of lymphoproliferation. The mechanism of the inhibitory effect of type IV or V hyperlipoproteinemic plasma upon the response tested was not identified by may be related to interaction between lipoproteins and the cell membranes. We suggest that these lipoproteins may also interfere with the function of other cells.
Similar articles
-
Control of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by very low density lipoproteins of subjects with hypertriglyceridemia.J Clin Invest. 1978 Feb;61(2):320-8. doi: 10.1172/JCI108942. J Clin Invest. 1978. PMID: 202612 Free PMC article.
-
Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man.J Clin Invest. 1973 Jul;52(7):1578-85. doi: 10.1172/JCI107334. J Clin Invest. 1973. PMID: 4352459 Free PMC article.
-
The clinical, biochemical, and familial presentation of type V hyperlipoproteinemia in childhood.Pediatrics. 1977 Apr;59(4):513-25. Pediatrics. 1977. PMID: 191790
-
Recent progress in the development of radioimmunoassays for human serum lipoproteins.Ann Clin Lab Sci. 1978 Mar-Apr;8(2):142-54. Ann Clin Lab Sci. 1978. PMID: 205163 Review.
-
[Primary type V hyperlipidemia].Nihon Rinsho. 2001 Mar;59 Suppl 3:34-7. Nihon Rinsho. 2001. PMID: 11347091 Review. Japanese. No abstract available.
Cited by
-
Inhibition of lymphocyte proliferation stimulated by lectins and allogeneic cells by normal plasma lipoproteins.J Exp Med. 1977 Dec 1;146(6):1791-803. doi: 10.1084/jem.146.6.1791. J Exp Med. 1977. PMID: 200701 Free PMC article.
-
Multiple serum inhibitors of lectin-induced lymphocyte proliferation in nephrotic syndrome.Clin Exp Immunol. 1981 Jul;45(1):178-84. Clin Exp Immunol. 1981. PMID: 7307346 Free PMC article.
-
Effect of indomethacin on lymphocyte response to mitogens in puromycin aminonucleoside nephrosis in the rat.Clin Exp Immunol. 1982 Sep;49(3):639-44. Clin Exp Immunol. 1982. PMID: 7172499 Free PMC article.
-
Oxidative modification of low density lipoprotein (LDL) by activated human monocytes and the cell lines U937 and HL60.In Vitro Cell Dev Biol. 1988 Oct;24(10):1001-8. doi: 10.1007/BF02620873. In Vitro Cell Dev Biol. 1988. PMID: 3182552
-
Acetylated lipoproteins impair erythroid growth factor release from endothelial cells.J Clin Invest. 1988 Mar;81(3):834-43. doi: 10.1172/JCI113392. J Clin Invest. 1988. PMID: 3278006 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources